Hany Elmariah
Associate Professor of Medicine · Stanford Health Care
Credentials: · · · · · · · ·
History
Research
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis
New England Journal of Medicine · 2023 · 550 citations
Factors associated with survival in a contemporary adult sickle cell disease cohort
American Journal of Hematology · 2014 · First of 8 authors · 242 citations
Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead
Review · Journal for ImmunoTherapy of Cancer · 2021 · 166 citations
- NB
28 papers
- TN
28 papers
- RF
26 papers
- JP
24 papers
- FK
23 papers
- AM
22 papers
- LP
21 papers
- AL
19 papers
Grants
- 2018–2024
PhI/II Study of CD8-Reduced T Cells for Treatment of MDS or AML IND17305 (12/30/2016)
Food and Drug Administration · R01
Contact PI · $729.1K · h. Lee Moffitt Cancer Ctr & Res Inst
Clinical trials
- 2026–2028
Automated Total Marrow and Lymphoid Irradiation for Allogeneic Hematopoietic Cell Transplant
Principal investigator · Not yet recruiting · Phase 2
Stanford University
- 2026–2029
Site PI · Recruiting · Phase 3
TScan Therapeutics, Inc.
- 2024–2028
Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy
Sub-investigator · Recruiting · Phase 2
H. Lee Moffitt Cancer Center and Research Institute